Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Ligand Interactions with Cholinergic Receptor-Enriched Membranes from Torpedo: Influence of Agonist Exposure on Receptor Properties

GREGORY WEILAND, BRIAN GEORGIA, VICTORIO T. WEE, COLIN F. CHIGNELL and PALMER TAYLOR
Molecular Pharmacology November 1976, 12 (6) 1091-1105;
GREGORY WEILAND
Division of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, California 92093, and Section on Molecular Pharmacology, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
BRIAN GEORGIA
Division of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, California 92093, and Section on Molecular Pharmacology, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VICTORIO T. WEE
Division of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, California 92093, and Section on Molecular Pharmacology, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
COLIN F. CHIGNELL
Division of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, California 92093, and Section on Molecular Pharmacology, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PALMER TAYLOR
Division of Pharmacology, Department of Medicine, University of California, San Diego, La Jolla, California 92093, and Section on Molecular Pharmacology, National Heart and Lung Institute, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Carbamylcholine and a nitrogen-substituted mononitroxide congener of decamethonium (I) show an inhibitory capacity toward the binding of cobra α-toxin to membranes enriched in cholinergic receptor that is dependent on the duration of exposure of the quaternary ligand prior to adding toxin. This behavior is characterized by (a) inhibition of the initial rate of toxin binding, which depends on the duration of ligand conditioning, (b) depression of the equilibrium binding of toxin, which at short exposure intervals cannot be accounted for by the decrease in association rate for toxin binding, and (c) a slow change in receptor state, in which the affinity for ligand is increased. The last can be demonstrated directly by electron spin resonance measurements of the free and bound resonance peaks of the spin-labeled bisquaternary ligand. The slow increase in affinity measured by ESR appears to be slightly smaller than the increased affinity calculated from conditioning effects of ligand exposure on the initial rate of toxin binding. The spin-labeled ligand is completely dissociated by excess toxin and binds to one site per toxin binding site. Conditioning effects of the ligands are lost upon solubilization of the receptor with Triton X-100. In contrast to the above ligands, the antagonist d-tubocurarine does not show time-dependent inhibition of toxin binding, and its interaction with the receptor-enriched membranes appears to be competitive with toxin binding.

  • Copyright © 1976 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 12, Issue 6
1 Nov 1976
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Ligand Interactions with Cholinergic Receptor-Enriched Membranes from Torpedo: Influence of Agonist Exposure on Receptor Properties
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Ligand Interactions with Cholinergic Receptor-Enriched Membranes from Torpedo: Influence of Agonist Exposure on Receptor Properties

GREGORY WEILAND, BRIAN GEORGIA, VICTORIO T. WEE, COLIN F. CHIGNELL and PALMER TAYLOR
Molecular Pharmacology November 1, 1976, 12 (6) 1091-1105;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Ligand Interactions with Cholinergic Receptor-Enriched Membranes from Torpedo: Influence of Agonist Exposure on Receptor Properties

GREGORY WEILAND, BRIAN GEORGIA, VICTORIO T. WEE, COLIN F. CHIGNELL and PALMER TAYLOR
Molecular Pharmacology November 1, 1976, 12 (6) 1091-1105;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • LYN Kinase and Tyrosine Kinase Inhibitors Regulate OATP1B3
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics